Nano cap Applied DNA Sciences (NASDAQ:APDN) and COVID-19 vaccine development partner Takis Biotech announce that
the first injections of their DNA vaccine candidates against the
SARS-CoV-2 spike protein produced neutralizing antibodies in test
animals in work performed in Italy.
Linear DNA dose-response studies will start this week.
https://seekingalpha.com/news/3568107-applied-dna-sciences-up-24-premarket-on-encouraging-covidminus-19-vaccine-data
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.